128 related articles for article (PubMed ID: 34924132)
1. Nafamostat protects against early brain injury after subarachnoid hemorrhage in mice.
Matsubara H; Imai T; Tsuji S; Oka N; Egashira Y; Enomoto Y; Nakayama N; Nakamura S; Shimazawa M; Iwama T; Hara H
J Pharmacol Sci; 2022 Jan; 148(1):65-72. PubMed ID: 34924132
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood-spinal cord barrier breakdown during acute spinal cord injury in rats.
Zhao C; Zhou T; Zhao X; Pang Y; Li W; Fan B; Li M; Liu X; Ma L; Zhang J; Sun C; Shen W; Kong X; Yao X; Feng S
J Neuroinflammation; 2022 Jul; 19(1):189. PubMed ID: 35842640
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice.
Sozen T; Tsuchiyama R; Hasegawa Y; Suzuki H; Jadhav V; Nishizawa S; Zhang JH
Stroke; 2009 Jul; 40(7):2519-25. PubMed ID: 19461019
[TBL] [Abstract][Full Text] [Related]
4. Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage.
Wan H; Wang Y; Ai J; Brathwaite S; Ni H; Macdonald RL; Hol EM; Meijers JCM; Vergouwen MDI
J Thromb Haemost; 2018 Jul; 16(7):1413-1422. PubMed ID: 29729651
[TBL] [Abstract][Full Text] [Related]
5. MST1 Suppression Reduces Early Brain Injury by Inhibiting the NF-
Qu J; Zhao H; Li Q; Pan P; Ma K; Liu X; Feng H; Chen Y
Behav Neurol; 2018; 2018():6470957. PubMed ID: 30018671
[TBL] [Abstract][Full Text] [Related]
6. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage.
Yatsushige H; Ostrowski RP; Tsubokawa T; Colohan A; Zhang JH
J Neurosci Res; 2007 May; 85(7):1436-48. PubMed ID: 17410600
[TBL] [Abstract][Full Text] [Related]
7. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
8. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
[TBL] [Abstract][Full Text] [Related]
9. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage.
Feiler S; Plesnila N; Thal SC; Zausinger S; Schöller K
Cerebrovasc Dis; 2011; 32(3):289-95. PubMed ID: 21912109
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of pyroptosis and neuroinflammation.
Chen J; Zhang C; Yan T; Yang L; Wang Y; Shi Z; Li M; Chen Q
J Cell Physiol; 2021 Oct; 236(10):6920-6931. PubMed ID: 33792028
[TBL] [Abstract][Full Text] [Related]
11. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage.
Kaminogo M; Yonekura M; Onizuka M; Yasunaga A; Shibata S
Neurol Med Chir (Tokyo); 1998 Nov; 38(11):704-8; discussion 708-9. PubMed ID: 9919901
[TBL] [Abstract][Full Text] [Related]
12. Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats.
Fang R; Zheng X; Zhang M
Acta Neurochir (Wien); 2016 Jun; 158(6):1069-76. PubMed ID: 27072679
[TBL] [Abstract][Full Text] [Related]
13. Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis.
Xu H; Cai Y; Yu M; Sun J; Cai J; Li J; Qin B; Ying G; Chen T; Shen Y; Jie L; Xu D; Gu C; Wang C; Hu X; Chen J; Wang L; Chen G
Aging (Albany NY); 2021 Jun; 13(12):16816-16833. PubMed ID: 34182541
[TBL] [Abstract][Full Text] [Related]
14. Acute cardiac support with intravenous milrinone promotes recovery from early brain injury in a murine model of severe subarachnoid haemorrhage.
Mutoh T; Mutoh T; Nakamura K; Yamamoto Y; Tsuru Y; Tsubone H; Ishikawa T; Taki Y
Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):463-469. PubMed ID: 28008646
[TBL] [Abstract][Full Text] [Related]
15. Matrine alleviates early brain injury after experimental subarachnoid hemorrhage in rats: possible involvement of PI3K/Akt-mediated NF-κB inhibition and Keap1/Nrf2-dependent HO-1 inductionn.
Liu X; Zhang X; Ma K; Zhang R; Hou P; Sun B; Yuan S; Wang Z; Liu Z
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):38-44. PubMed ID: 27755950
[TBL] [Abstract][Full Text] [Related]
16. Inotropic support against early brain injury improves cerebral hypoperfusion and outcomes in a murine model of subarachnoid hemorrhage.
Mutoh T; Mutoh T; Nakamura K; Sasaki K; Tatewaki Y; Ishikawa T; Taki Y
Brain Res Bull; 2017 Apr; 130():18-26. PubMed ID: 28017781
[TBL] [Abstract][Full Text] [Related]
17. Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity.
Pang J; Wu Y; Peng J; Yang P; Kuai L; Qin X; Cao F; Sun X; Chen L; Vitek MP; Jiang Y
Oncotarget; 2016 Aug; 7(35):56030-56044. PubMed ID: 27463015
[TBL] [Abstract][Full Text] [Related]
18. The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage.
Ayer R; Jadhav V; Sugawara T; Zhang JH
Acta Neurochir Suppl; 2011; 111():145-9. PubMed ID: 21725746
[TBL] [Abstract][Full Text] [Related]
19. Protection of minocycline on early brain injury after subarachnoid hemorrhage in rats.
Guo ZD; Wu HT; Sun XC; Zhang XD; Zhang JH
Acta Neurochir Suppl; 2011; 110(Pt 1):71-4. PubMed ID: 21116918
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E Deficiency Aggravates Neuronal Injury by Enhancing Neuroinflammation via the JNK/c-Jun Pathway in the Early Phase of Experimental Subarachnoid Hemorrhage in Mice.
Wu Y; Pang J; Peng J; Cao F; Guo Z; Jiang L; Teng Z; Huang Z; Cheng C; Jiang Y; Sun X
Oxid Med Cell Longev; 2019; 2019():3832648. PubMed ID: 31949876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
